Opko Health Inc (OPK)

Feb 01, 2025

OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 47,537 Shares - MarketBeat

Feb 01, 2025

Jan 28, 2025

Opko health CEO Phillip Frost buys $70,060 in stock - MSN

Jan 28, 2025

Jan 28, 2025

Clinical Laboratory Tests Market Generated Opportunities, - openPR

Jan 28, 2025

Jan 28, 2025

Clinical Laboratory Tests Market Key Players AnalysisARUP - openPR

Jan 28, 2025

Jan 24, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 24, 2025

Jan 22, 2025

Billionaire Phillip Frost's health care company settles case with federal government - The Business Journals

Jan 22, 2025

Jan 20, 2025

OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Insider Monkey

Jan 20, 2025

Jan 20, 2025

12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey

Jan 20, 2025

Jan 20, 2025

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN

Jan 20, 2025

Jan 20, 2025

3 Stocks That Wall Street Insiders Can't Stop Buying - MSN

Jan 20, 2025

Jan 19, 2025

BioReference faces $704,349 fine for medically unnecessary blood tests - MSN

Jan 19, 2025

Jan 19, 2025

Opko health CEO Phillip Frost buys $220,425 in common stock - MSN

Jan 19, 2025

Jan 18, 2025

OPKO Health : Immediate Report -January 18, 2025 at 06:29 am EST - Marketscreener.com

Jan 18, 2025

Jan 18, 2025

Opko health CEO Phillip Frost buys $220,425 in common stock By Investing.com - Investing.com Australia

Jan 18, 2025

Jan 17, 2025

Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat

Jan 17, 2025

Jan 17, 2025

BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the - U.S. Politics Today

Jan 17, 2025

Jan 17, 2025

BioReference Health, OPKO Health Settle False Claims Violations - Bloomberg Law

Jan 17, 2025

Jan 16, 2025

Opko health CEO Phillip Frost buys $740,850 in stock By Investing.com - Investing.com South Africa

Jan 16, 2025

Jan 16, 2025

Barclays PLC Acquires 329,870 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jan 16, 2025

Jan 16, 2025

Opko health CEO Phillip Frost buys $740,850 in stock - Investing.com India

Jan 16, 2025

Jan 15, 2025

OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $740,000.00 in Stock - MarketBeat

Jan 15, 2025

Jan 15, 2025

Opko Health Engages Investors at J.P. Morgan Conference - TipRanks

Jan 15, 2025

Jan 15, 2025

OPKO Health (NASDAQ:OPK) Stock Rating Lowered by StockNews.com - MarketBeat

Jan 15, 2025

Jan 14, 2025

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN

Jan 14, 2025

Jan 14, 2025

OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Could Signal Some Risk - Simply Wall St

Jan 14, 2025

Jan 10, 2025

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 10, 2025

Jan 08, 2025

Opko Health stock buy rating reaffirmed, steady target on clinical trial - Investing.com Canada

Jan 08, 2025

Jan 08, 2025

OPKO Health's (OPK) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Jan 08, 2025

Jan 07, 2025

OPKO Health (NASDAQ:OPK) Upgraded by StockNews.com to "Hold" Rating - MarketBeat

Jan 07, 2025

Jan 07, 2025

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr - GlobeNewswire

Jan 07, 2025

Jan 07, 2025

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck - Yahoo Finance

Jan 07, 2025

Jan 06, 2025

OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Jan 06, 2025

Dec 31, 2024

OPKO Health, Inc. (NASDAQ:OPK) Stake Cut by Geode Capital Management LLC - MarketBeat

Dec 31, 2024

Dec 30, 2024

3 Stocks That Wall Street Insiders Can’t Stop Buying - sharewise

Dec 30, 2024